Almujtama Alraida Medical Co (SAU:9592) PE Ratio: 24.41 (As of Aug. 19, 2026) — 19% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9592 Almujtama Alraida Medical Co SAU:9592
13 GF Score
Price ﷼21.48
! 4 Warning Signs
View Full Analysis

What is Almujtama Alraida Medical Co PE Ratio?

Almujtama Alraida Medical Co SAU:9592 13 PE Ratio is 24.41 as of Aug. 19, 2026, which is 19% below its 10-year median of 30.24. GuruFocus rates SAU:9592 with a GF Score™ of 13/100. The stock has 4 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-19), Almujtama Alraida Medical Co's share price is ﷼21.48. Almujtama Alraida Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼0.88. Therefore, Almujtama Alraida Medical Co's PE Ratio for today is 24.41.

Good Sign:

Almujtama Alraida Medical Co stock PE Ratio (=24.41) is close to 2-year low of 24.41.

During the past 5 years, Almujtama Alraida Medical Co's highest PE Ratio was 40.36. The lowest was 14.47. And the median was 30.24.

Almujtama Alraida Medical Co's EPS (Diluted) for the six months ended in Dec. 2025 was ﷼0.43. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼0.88.

As of today (2026-08-19), Almujtama Alraida Medical Co's share price is ﷼21.48. Almujtama Alraida Medical Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼0.88. Therefore, Almujtama Alraida Medical Co's PE Ratio without NRI ratio for today is 24.41.

During the past 5 years, Almujtama Alraida Medical Co's highest PE Ratio without NRI was 40.36. The lowest was 14.47. And the median was 30.24.

Almujtama Alraida Medical Co's EPS without NRI for the six months ended in Dec. 2025 was ﷼0.43. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼0.88.

During the past 12 months, Almujtama Alraida Medical Co's average EPS without NRI Growth Rate was 6.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was -24.00% per year.

During the past 5 years, Almujtama Alraida Medical Co's highest 3-Year average EPS without NRI Growth Rate was 0.30% per year. The lowest was -24.00% per year. And the median was -11.85% per year.

Almujtama Alraida Medical Co's EPS (Basic) for the six months ended in Dec. 2025 was ﷼0.43. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼0.88.

Back to Basics: PE Ratio


Almujtama Alraida Medical Co  (SAU:9592) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Almujtama Alraida Medical Co PE Ratio Related Terms


Almujtama Alraida Medical Co PE Ratio Historical Data

* Premium members only.

The historical data trend for Almujtama Alraida Medical Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almujtama Alraida Medical Co PE Ratio Chart

Almujtama Alraida Medical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
N/A N/A 25.00 37.17 33.75

Almujtama Alraida Medical Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio Get a 7-Day Free Trial Premium Member Only 25.00 At Loss 37.17 At Loss 33.75

Almujtama Alraida Medical Co PE Ratio Competitor Comparison

For the Pharmaceutical Retailers subindustry, Almujtama Alraida Medical Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Almujtama Alraida Medical Co PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Almujtama Alraida Medical Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Almujtama Alraida Medical Co's PE Ratio falls into.


SAU:9592
13GF Score
Almujtama Alraida Medical Co SAU:9592
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almujtama Alraida Medical Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Almujtama Alraida Medical Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=21.48/0.880
=24.41

Almujtama Alraida Medical Co's Share Price of today is ﷼21.48.
For company reported semi-annually, Almujtama Alraida Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ﷼0.88.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 24.41 mean?
Almujtama Alraida Medical Co (SAU:9592) has a PE Ratio of 24.41 as of Aug. 19, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Almujtama Alraida Medical Co and its competitors. This is 19% below median its historical median of 30.24. Over the past decade, Almujtama Alraida Medical Co's PE Ratio has ranged from 14.47 to 40.36.
Is Almujtama Alraida Medical Co's PE Ratio too high?
Almujtama Alraida Medical Co's current PE Ratio of 24.41 is 19% below median its 10-year median of 30.24. Over the past 10 years, this metric has ranged from a low of 14.47 to a high of 40.36. Overall, Almujtama Alraida Medical Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Almujtama Alraida Medical Co's PE Ratio compare to competitors?
Almujtama Alraida Medical Co's PE Ratio of 24.41 can be compared against companies in the Healthcare Providers & Services industry. Historically, Almujtama Alraida Medical Co's own PE Ratio has ranged from 14.47 to 40.36 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Healthcare Providers & Services company?
A good PE Ratio depends on the Healthcare Providers & Services industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Almujtama Alraida Medical Co and its competitors. Almujtama Alraida Medical Co's current PE Ratio is 24.41, which is 19% below median its own 10-year median of 30.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almujtama Alraida Medical Co stock overvalued right now?
Almujtama Alraida Medical Co (SAU:9592) has a current PE Ratio of 24.41. The current PE Ratio is 24.41, which is 19% below median its 10-year median of 30.24. Almujtama Alraida Medical Co's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Almujtama Alraida Medical Co (SAU:9592), the current PE Ratio is 24.41 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Almujtama Alraida Medical Co Business Description

Address Main Street, P.O. Box 109474, Al-Hamadania District, Jeddah, SAU, 21351
Almujtama Alraida Medical Co is a company having its core operations include operating pharmacies and retailing pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies. It also provides pharmaceutical services in the Kingdom of Saudi Arabia.
13GF Score

Get the complete analysis for SAU:9592

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼21.48
Price